193 related articles for article (PubMed ID: 7906606)
1. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potential.
Iino H; Fukayama M; Maeda Y; Koike M; Mori T; Takahashi T; Kikuchi-Yanoshita R; Miyaki M; Mizuno S; Watanabe S
Cancer; 1994 Mar; 73(5):1324-31. PubMed ID: 7906606
[TBL] [Abstract][Full Text] [Related]
2. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
Gao S; Xu W; Wan Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis.
Fukunari H; Iwama T; Sugihara K; Miyaki M
Surg Today; 2003; 33(6):408-13. PubMed ID: 12768365
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
[TBL] [Abstract][Full Text] [Related]
6. [Accumulation of genetic alterations during human tumor progression].
Yokota J; Ookawa K
Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma.
Kashiwaba M; Tamura G; Ishida M
Virchows Arch; 1995; 426(5):441-6. PubMed ID: 7633654
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
10. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms.
Fujii H; Ajioka Y; Kazami S; Takagaki T; Gong Zhu X; Hirose S; Watanabe H; Shirai T
J Pathol; 2002 Jul; 197(3):298-306. PubMed ID: 12115875
[TBL] [Abstract][Full Text] [Related]
12. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma.
Ookawa K; Sakamoto M; Hirohashi S; Yoshida Y; Sugimura T; Terada M; Yokota J
Int J Cancer; 1993 Feb; 53(3):382-7. PubMed ID: 8094072
[TBL] [Abstract][Full Text] [Related]
13. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
15. Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues.
Fearon ER; Ekstrand BC; Hu G; Pierceall WE; Reale MA; Bigner SH
Cold Spring Harb Symp Quant Biol; 1994; 59():637-43. PubMed ID: 7587124
[TBL] [Abstract][Full Text] [Related]
16. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of DCC mRNA in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Orita K
Surg Today; 1995; 25(12):1001-7. PubMed ID: 8645930
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas.
Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Orii S; Itoh C; Katoh R
Hum Pathol; 2000 Aug; 31(8):925-30. PubMed ID: 10987252
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Eur J Cancer; 1994; 30A(5):664-70. PubMed ID: 8080684
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.
Miyaki M; Seki M; Okamoto M; Yamanaka A; Maeda Y; Tanaka K; Kikuchi R; Iwama T; Ikeuchi T; Tonomura A
Cancer Res; 1990 Nov; 50(22):7166-73. PubMed ID: 1977514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
